| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |